- By James Kravitz
- (General Dispatch) – This Tuesday the U.S. Federal Health Agency will execute an order for Washington to immediately halt the launch of Johnson & Johnson’s single-dose vaccine.
- The executive order originates because it seems that the vaccine, as well as Astrazeneca, is presenting adverse effects post-supply, which generates blood clots in the organism.
- The warnings from the safety agencies come as a preventive mechanism to prevent further deaths from coronavirus immunization.
- However, Dr. Anne Schuchat, principal deputy director of the CDC and Dr. Peter Marks, director of the Center for Biologics Evaluation and Research of the Food and Drug Administration announced the incidence.
- In this regard, they spoke out against the strange behaviors that the vaccine is developing, it is alarming and new clinical trials should be conducted before it is given.
- “We are aware that thromboembolic events, including those with thrombocytopenia, have been reported with Covid-19 vaccines. At present, a clear causal relationship between these rare events and Janssen’s (J&J) Covid-19 vaccine has not been established.”
- For its part, the Johnson & Johnson company said it is conducting research to determine the behavior of the vaccine and will issue an official statement to make the evidence publicly available.
- In the meantime, the countries that have established commercial agreements with the corporation will have to wait for the company to solve the incident and provide a reliable and safe vaccine.
Adittional Information:
Breitbart: FDA, CDC Call for Immediate Pause of Johnson & Johnson Coronavirus Vaccine
The News York Times: Johnson & Johnson Vaccinations Paused After Rare Clotting Cases Emerge
Related Articles
